ArticleDiscover nano2026
High-fidelity machine learning models for predicting antibacterial effects of cerium oxide nanoparticles across bacterial strains.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The primary objective of this study is to develop and validate robust data-driven models for accurately predicting bacterial growth inhibition induced by cerium oxide nanoparticles across different bacterial strains and experimental conditions. This study aims to develop and validate data-driven predictive models to quantify bacterial growth inhibition induced by cerium oxide nanoparticles under diverse experimental conditions, with the goal of supporting antibacterial nanotechnology research. To this end, sophisticated AI methods, including Convolutional Neural Networks (CNN), Multi-layer Perceptron Artificial Neural Networks (MLP-ANN), Random Forest (RF), Adaptive Boosting (AdaBoost), and Ensemble Learning (EL), were employed to model bacterial cell concentration (OD600) with high precision. Model hyperparameters were optimized using the Coupled Simulated Annealing (CSA) technique to enhance predictive performance. A comprehensive dataset comprising 484 experimental observations was compiled, with 387 samples allocated for training and 97 for validation. The study considers two bacterial strains, Escherichia coli and Bacillus subtilis, cultivated in media containing cerium oxide nanoparticles with nominal sizes of 6 ± 3.5 nm, 15 ± 4.3 nm, 22 ± 5.7 nm, and 40 ± 10 nm (Samples A-D). Input features included bacterial type, nanoparticle size (medium type), nanoparticle concentration, and exposure time. Monte Carlo sensitivity analysis revealed that exposure time is the dominant factor governing bacterial cell concentration, followed by nanoparticle concentration, nanoparticle size, and bacterial strain. Among the evaluated models, MLP-ANN exhibited the highest predictive accuracy, achieving the greatest R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.